MAGE-12 peptide vaccine
Term · Oncology and biomedicine · MLC-T-ONC-014963
A synthetic vaccine comprised of a peptide consisting of peptide fragments of melanoma-associated antigen 12 (MAGE-12). MAGE-12 has been identified as an epitope recognized by tumor infiltrating lymphocytes (TIL). Vaccination with MAGE-12 peptide stimulates the host immune system to mount a TIL response against tumor cells expressing MAGE-12, potentially resulting in decreased tumor growth.
| Identifier | MLC-T-ONC-014963 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014963",
"term": "MAGE-12 peptide vaccine",
"field": "Oncology and biomedicine",
"definition": "A synthetic vaccine comprised of a peptide consisting of peptide fragments of melanoma-associated antigen 12 (MAGE-12). MAGE-12 has been identified as an epitope recognized by tumor infiltrating lymphocytes (TIL). Vaccination with MAGE-12 peptide stimulates the host immune system to mount a TIL response against tumor cells expressing MAGE-12, potentially resulting in decreased tumor growth.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/mage-12-peptide-vaccine/"
}
Record 10,529 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.